NL-OMON37671已完成2 期
Effects of acute and chronic oral administration of S 44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1 - A randomized, parallel-group, international multicentre study including a 8-week double-blind placebo controlled period followed by a 8-week single-blind period - Phase II exploratory study - S44121 in CPVT
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Male or female patients aged 18 years or more;- Established diagnosis of CPVT type 1;- Treatment with beta-blocker;- Qualifying ETs meeting a predefined degree of severity and stability of the disease;- Presence of an ICD for primary or secondary prevention of ventricular arrhythmia implanted at least 3 months prior to pre-selection
排除标准
- •- Resting ECG with an abnormality that could preclude a proper interpretation of the ECG obtained during the ETs;- Chronic heart failure;- Structural congenital heart disease
研究者
相似试验
进行中（未招募）
1 期
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849EUCTR2011-000579-15-GBInstitut de Recherches Internationales Servier36
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849EUCTR2011-000579-15-DEInstitut de Recherches Internationales Servier
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1EUCTR2011-000579-15-FIInstitut de Recherches Internationales Servier
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1EUCTR2011-000579-15-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER36
进行中（未招募）
不适用
Effects of acute and chronic oral administration of S44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1Catecholaminergic polymorphic ventricular tachycardia type 1MedDRA version: 14.1Level: LLTClassification code 10036095Term: Polymorphic ventricular tachycardiaSystem Organ Class: 100000004849EUCTR2011-000579-15-HUInstitut de Recherches Internationales Servier36